Patients with metastatic ER positive breast cancer are typically treated with endocrine therapy, such as aromatase inhibitors or fulvestrant Faslodex; however, resistance to these treatments commonly develops, in some cases due to mutation of the ESR1 gene
cialis 20 mg
